Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 TheratechnologiesBiotestKodiak SciencesStarpharmaBELLUS Health
SymbolTSE:THETR:BIONYSE:KODASX:SPLTSE:BLU
Price Information
Current PriceC$5.76€22.70$16.64A$1.14C$9.69
52 Week RangeBuyN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price TargetC$9.56N/A$19.1250N/AN/A
% Upside from Price Target66.02% upsideN/A14.93% upsideN/AN/A
Trade Information
Market CapC$425.43 million$449.14 million$617.14 million$421.90 millionC$536.57 million
BetaN/AN/AN/AN/AN/A
Average Volume133,1991,927123,173544,82469,583
Sales & Book Value
Annual RevenueC$56.31 million$394.70 millionN/A$2.72 millionC$35,000.00
Price / Sales7.451.14N/A155.1115,330.69
CashflowC$0.53 per share€1.79 per shareN/AA$0.11 per shareC$0.95 per share
Price / Cash10.8812.70N/A10.2310.16
Book ValueC$0.41 per share€10.85 per shareN/AA$0.11 per shareC$0.89 per share
Price / Book14.152.09N/A9.9610.85
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.06)(€0.05)N/AA($0.04)C($0.47)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E Ratio
P/E GrowthC($1,916.82)N/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/A€0.04N/AN/AN/A
Dividend YieldN/A0.18%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio159.35%71.50%N/A0.06%0.56%
Current Ratio2.69%1.18%N/A7.44%6.11%
Quick Ratio2.09%0.54%N/A7.37%6.04%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees321,663N/AN/A10
Shares Outstanding72.85 million19.79 million36.93 million371.72 million55.37 million
Next Earnings Date10/3/2019 (Estimated)N/A11/15/2019 (Estimated)N/A11/13/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
 TheratechnologiesBiotestKodiak SciencesStarpharmaBELLUS Health

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel